Published in Kidney Int on April 01, 2000
Polycystic kidney disease. Annu Rev Med (2009) 4.78
Sirolimus reduces polycystic liver volume in ADPKD patients. J Am Soc Nephrol (2008) 2.26
Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1. Hum Mol Genet (2008) 2.23
Neural regulation of lacrimal gland secretory processes: relevance in dry eye diseases. Prog Retin Eye Res (2009) 2.04
Molecular advances in autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis (2010) 1.77
Hyperproliferation of PKD1 cystic cells is induced by insulin-like growth factor-1 activation of the Ras/Raf signalling system. Kidney Int (2007) 1.73
Sorafenib inhibits cAMP-dependent ERK activation, cell proliferation, and in vitro cyst growth of human ADPKD cyst epithelial cells. Am J Physiol Renal Physiol (2010) 1.58
The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD). Hepatology (2009) 1.58
Does increased water intake prevent disease progression in autosomal dominant polycystic kidney disease? Nephrol Dial Transplant (2014) 1.55
The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-β1 biliary secretion in mice. Hepatology (2016) 1.45
Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease. Kidney Int (2011) 1.44
Determinants of renal volume in autosomal-dominant polycystic kidney disease. Kidney Int (2007) 1.44
Src inhibition ameliorates polycystic kidney disease. J Am Soc Nephrol (2008) 1.43
Tolvaptan inhibits ERK-dependent cell proliferation, Cl⁻ secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin. Am J Physiol Renal Physiol (2011) 1.40
Physiology and pathophysiology of the vasopressin-regulated renal water reabsorption. Pflugers Arch (2008) 1.37
Strategies targeting cAMP signaling in the treatment of polycystic kidney disease. J Am Soc Nephrol (2013) 1.33
Polycystin-1 induces resistance to apoptosis through the phosphatidylinositol 3-kinase/Akt signaling pathway. J Am Soc Nephrol (2006) 1.23
Periostin induces proliferation of human autosomal dominant polycystic kidney cells through alphaV-integrin receptor. Am J Physiol Renal Physiol (2008) 1.21
Cyclic AMP-mediated cyst expansion. Biochim Biophys Acta (2010) 1.21
Cell biology of polycystin-2. Cell Signal (2006) 1.21
Activation of Trpv4 reduces the hyperproliferative phenotype of cystic cholangiocytes from an animal model of ARPKD. Gastroenterology (2010) 1.20
Autosomal recessive polycystic kidney disease: a hepatorenal fibrocystic disorder with pleiotropic effects. Pediatrics (2014) 1.14
The exocyst protein Sec10 interacts with Polycystin-2 and knockdown causes PKD-phenotypes. PLoS Genet (2011) 1.11
Emerging evidence of a link between the polycystins and the mTOR pathways. Pathogenetics (2009) 1.09
The small GTPase Cdc42 is necessary for primary ciliogenesis in renal tubular epithelial cells. J Biol Chem (2011) 1.06
Conditional mutation of Pkd2 causes cystogenesis and upregulates beta-catenin. J Am Soc Nephrol (2009) 1.02
Neutrophil gelatinase-associated lipocalin suppresses cyst growth by Pkd1 null cells in vitro and in vivo. Kidney Int (2008) 1.02
Xenin-25 potentiates glucose-dependent insulinotropic polypeptide action via a novel cholinergic relay mechanism. J Biol Chem (2010) 1.00
Diagnosis and management of childhood polycystic kidney disease. Pediatr Nephrol (2010) 0.99
A pilot clinical study to evaluate changes in urine osmolality and urine cAMP in response to acute and chronic water loading in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol (2010) 0.94
Tolvaptan plus pasireotide shows enhanced efficacy in a PKD1 model. J Am Soc Nephrol (2014) 0.94
Novel targets for the treatment of autosomal dominant polycystic kidney disease. Expert Opin Investig Drugs (2010) 0.94
Molecular pathways and therapies in autosomal-dominant polycystic kidney disease. Physiology (Bethesda) (2015) 0.93
Endogenous concentrations of ouabain act as a cofactor to stimulate fluid secretion and cyst growth of in vitro ADPKD models via cAMP and EGFR-Src-MEK pathways. Am J Physiol Renal Physiol (2012) 0.93
Collecting duct cells that lack normal cilia have mislocalized vasopressin-2 receptors. Am J Physiol Renal Physiol (2011) 0.92
Inhibition of the P2X7 receptor reduces cystogenesis in PKD. J Am Soc Nephrol (2011) 0.91
Drug discovery for polycystic kidney disease. Acta Pharmacol Sin (2011) 0.90
Network analysis of a Pkd1-mouse model of autosomal dominant polycystic kidney disease identifies HNF4α as a disease modifier. PLoS Genet (2012) 0.90
Vasopressin and disruption of calcium signalling in polycystic kidney disease. Nat Rev Nephrol (2015) 0.89
Inhibition of intrahepatic bile duct dilation of the polycystic kidney rat with a novel tyrosine kinase inhibitor gefitinib. Am J Pathol (2006) 0.88
Calcium-mediated mechanisms of cystic expansion. Biochim Biophys Acta (2010) 0.88
Ouabain activates the Na-K-ATPase signalosome to induce autosomal dominant polycystic kidney disease cell proliferation. Am J Physiol Renal Physiol (2011) 0.87
Rosiglitazone inhibits transforming growth factor-β1 mediated fibrogenesis in ADPKD cyst-lining epithelial cells. PLoS One (2011) 0.86
Downregulation of PKD1 by shRNA results in defective osteogenic differentiation via cAMP/PKA pathway in human MG-63 cells. J Cell Biochem (2012) 0.85
Impaired formation of desmosomal junctions in ADPKD epithelia. Histochem Cell Biol (2005) 0.84
New insights into ciliary function: kidney cysts and photoreceptors. Proc Natl Acad Sci U S A (2003) 0.84
Insignificant effect of secretin in rodent models of polycystic kidney and liver disease. Am J Physiol Renal Physiol (2012) 0.84
Pathophysiology of childhood polycystic kidney diseases: new insights into disease-specific therapy. Pediatr Res (2013) 0.84
Calmodulin-sensitive adenylyl cyclases mediate AVP-dependent cAMP production and Cl- secretion by human autosomal dominant polycystic kidney cells. Am J Physiol Renal Physiol (2012) 0.84
The cleaved cytoplasmic tail of polycystin-1 regulates Src-dependent STAT3 activation. J Am Soc Nephrol (2014) 0.83
Prostaglandin E(2) mediates proliferation and chloride secretion in ADPKD cystic renal epithelia. Am J Physiol Renal Physiol (2012) 0.83
Pretransplant genetic testing of live kidney donors at risk for autosomal dominant polycystic kidney disease. Transplantation (2009) 0.82
A review on renal toxicity profile of common abusive drugs. Korean J Physiol Pharmacol (2013) 0.82
Cilia movement regulates expression of the Raf-1 kinase inhibitor protein. Am J Physiol Renal Physiol (2011) 0.81
Phosphodiesterase Isoform Regulation of Cell Proliferation and Fluid Secretion in Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol (2015) 0.81
Polycystic kidney disease: In danger of being X-rated? Proc Natl Acad Sci U S A (2001) 0.80
Treatment of autosomal dominant polycystic kidney disease (ADPKD): the new horizon for children with ADPKD. Pediatr Nephrol (2008) 0.80
Vasopressin-2 receptor signaling and autosomal dominant polycystic kidney disease: from bench to bedside and back again. J Am Soc Nephrol (2014) 0.79
The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease. Nat Rev Nephrol (2015) 0.79
Abnormalities in focal adhesion complex formation, regulation, and function in human autosomal recessive polycystic kidney disease epithelial cells. Am J Physiol Cell Physiol (2009) 0.78
Polycystin: from structure to function. Kidney Int (2000) 0.78
Polycystins and cellular Ca2+ signaling. Cell Mol Life Sci (2012) 0.78
Safety study of somatostatin analogue octreotide for autosomal dominant polycystic kidney disease in Japan. Clin Exp Nephrol (2014) 0.78
Novel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney disease. Am J Physiol Renal Physiol (2013) 0.78
Calcium-phosphate metabolism parameters and erythrocyte Ca(2+) concentration in autosomal dominant polycystic kidney disease patients with normal renal function. Arch Med Sci (2012) 0.77
The cAMP Signaling Pathway and Direct Protein Kinase A Phosphorylation Regulate Polycystin-2 (TRPP2) Channel Function. J Biol Chem (2015) 0.77
ADPKD: molecular characterization and quest for treatment. Clin Exp Nephrol (2005) 0.77
Polycystic kidney disease: Polycystin-1 and polycystin-2--it's complicated. Nat Rev Nephrol (2013) 0.77
Cyst growth, polycystins, and primary cilia in autosomal dominant polycystic kidney disease. Kidney Res Clin Pract (2014) 0.77
Novel therapeutic approaches to autosomal dominant polycystic kidney disease. Transl Res (2014) 0.76
Systems biology of polycystic kidney disease: a critical review. Wiley Interdiscip Rev Syst Biol Med (2015) 0.75
The Jeremiah Metzger Lecture. Polycystic kidney disease: old disease in a new context. Trans Am Clin Climatol Assoc (2002) 0.75
Pathways, perspectives and pursuits in polycystic kidney disease. J Nephropharmacol (2015) 0.75
Dose-Titrated Vasopressin V2 Receptor Antagonist Improves Renoprotection in a Mouse Model for Autosomal Dominant Polycystic Kidney Disease. Am J Nephrol (2016) 0.75
Renal Tubular Cyst Formation in Newborn Rats Treated with p-Cumylphenol. J Toxicol Pathol (2009) 0.75
The regulatory 1α subunit of protein kinase A modulates renal cystogenesis. Am J Physiol Renal Physiol (2017) 0.75
Generation and phenotypic characterization of Pde1a mutant mice. PLoS One (2017) 0.75
Effect of vasopressin and cyclic AMP on permeability of isolated collecting tubules. Am J Physiol (1966) 4.19
Effect of prostaglandin E1 on the permeability response of the isolated collecting tubule to vasopressin, adenosine 3',5'-monophosphate, and theophylline. J Clin Invest (1968) 2.76
Cyst formation and growth in autosomal dominant polycystic kidney disease. Kidney Int (1987) 2.16
Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis (1992) 2.11
Ultrastructural studies of vasopressin effect on isolated perfused renal collecting tubules of the rabbit. J Cell Biol (1968) 2.06
Inhibition of macrophage migration by muramyl peptides. Infect Immun (1979) 1.91
The nature of transtubular Na and K transport in isolated rabbit renal collecting tubules. J Clin Invest (1970) 1.88
Physical properties of isolated perfused renal tubules and tubular basement membranes. J Clin Invest (1972) 1.86
Stimulation of the reticuloendothelial system of mice by muramyl dipeptide. Infect Immun (1979) 1.84
Calcium channel inhibition accelerates polycystic kidney disease progression in the Cy/+ rat. Kidney Int (2007) 1.83
Exacerbation of familial renal lymphangiomatosis during pregnancy. AJR Am J Roentgenol (1988) 1.75
Effect of vasopressin on electrical resistance of renal cortical collecting tubules. Am J Physiol (1971) 1.65
Progressive renal fibrosis in murine polycystic kidney disease: an immunohistochemical observation. Kidney Int (2000) 1.58
Immunobiologically active lipid A analogs synthesized according to a revised structural model of natural lipid A. Infect Immun (1984) 1.57
Paths of transtubular water flow in isolated renal collecting tubules. J Cell Biol (1969) 1.57
The genetics and physiology of polycystic kidney disease. Semin Nephrol (2001) 1.57
Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin. J Biol Chem (2000) 1.53
Inhibition of macrophage migration by synthetic muramyl dipeptide. Biochem Biophys Res Commun (1978) 1.53
Proteasomes in distal myopathy with rimmed vacuoles. Intern Med (1998) 1.53
Memory trace of motor learning shifts transsynaptically from cerebellar cortex to nuclei for consolidation. Neuroscience (2006) 1.52
Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines. Mol Carcinog (2000) 1.50
Correlation of stereochemically specific structure in muramyl dipeptide between macrophage activation and adjuvant activity. Biochem Biophys Res Commun (1977) 1.47
Epithelial transport in polycystic kidney disease. Physiol Rev (1998) 1.45
Intraarterial infusion of papaverine in experimental cerebral vasospasm. AJNR Am J Neuroradiol (1997) 1.40
Regulation of renal tubule cell volume in hypotonic media. Am J Physiol (1973) 1.39
Mitogenic effects of bacterial cell walls, their fragments, and related synthetic compounds on thymocytes and splenocytes of guinea pigs. Infect Immun (1979) 1.36
Relating aromatic hydrocarbon-induced DNA adducts and c-H-ras mutations in mouse skin papillomas: the role of apurinic sites. Proc Natl Acad Sci U S A (1995) 1.35
Spatial resolution of fodrin proteolysis in postischemic brain. J Biol Chem (1993) 1.35
Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin. Clin Cancer Res (1999) 1.35
Ultrastructure and function of cysts from human adult polycystic kidneys. Kidney Int (1980) 1.34
Enhanced superoxide anion release from phagocytes by muramyl dipeptide or lipopolysaccharide. Infect Immun (1983) 1.32
Muramyl dipeptide-induced adjuvant arthritis. Infect Immun (1980) 1.32
The cystic fibrosis transmembrane conductance regulator mediates transepithelial fluid secretion by human autosomal dominant polycystic kidney disease epithelium in vitro. Kidney Int (1996) 1.28
The amino acid sequence of the Tetrahymena calmodulin which specifically interacts with guanylate cyclase. Biochem Biophys Res Commun (1981) 1.27
Amelioration of murine experimental colitis by inhibition of mucosal addressin cell adhesion molecule-1. J Pharmacol Exp Ther (2000) 1.24
Ca2+-dependent modulator proteins from Tetrahymena pyriformis, sea anemone, and scallop and guanylate cyclase activation. J Biol Chem (1981) 1.23
Volumetric determination of progression in autosomal dominant polycystic kidney disease by computed tomography. Kidney Int (2000) 1.22
Elevated proto-oncogene expression in polycystic kidneys of the C57BL/6J (cpk) mouse. J Am Soc Nephrol (1991) 1.22
The secretion of fluid by renal cysts from patients with autosomal dominant polycystic kidney disease. N Engl J Med (1993) 1.22
Renal epithelial cyst formation and enlargement in vitro: dependence on cAMP. Proc Natl Acad Sci U S A (1989) 1.19
Macrophage activation by muramyl dipeptide as measured by macrophage spreading and attachment. Microbiol Immunol (1980) 1.18
A hereditary model of slowly progressive polycystic kidney disease in the mouse. J Am Soc Nephrol (1991) 1.16
Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease. Am J Kidney Dis (1997) 1.16
Acquired cystic disease: replacing one kidney disease with another. Kidney Int (1985) 1.15
Immunolocalization of ion transport proteins in human autosomal dominant polycystic kidney epithelial cells. Proc Natl Acad Sci U S A (1996) 1.15
Renal epithelial fluid secretion and cyst growth: the role of cyclic AMP. FASEB J (1989) 1.13
In vivo demonstration of T lymphocyte migration and amelioration of ileitis in intestinal mucosa of SAMP1/Yit mice by the inhibition of MAdCAM-1. Clin Exp Immunol (2005) 1.13
Elevated c-myc protooncogene expression in autosomal recessive polycystic kidney disease. Proc Natl Acad Sci U S A (1987) 1.12
Expression of bone morphogenetic proteins in colon carcinoma with heterotopic ossification. Pathol Int (2001) 1.12
Do rapid systemic changes of brain temperature have an influence on the brain? Acta Neurochir (Wien) (2003) 1.12
The chemopreventive flavonoid apigenin induces G2/M arrest in keratinocytes. Carcinogenesis (1996) 1.11
Cisplatin-induced response of c-jun N-terminal kinase 1 and extracellular signal--regulated protein kinases 1 and 2 in a series of cisplatin-resistant ovarian carcinoma cell lines. Mol Carcinog (2000) 1.10
Dynamic characteristics and adaptability of mouse vestibulo-ocular and optokinetic response eye movements and the role of the flocculo-olivary system revealed by chemical lesions. Proc Natl Acad Sci U S A (1998) 1.09
Acute intracranial hypertension and auditory brain-stem responses. Part 1: Changes in the aduitory brain-stem and somatosensory evoked responses in intracranial hypertension in cats. J Neurosurg (1979) 1.09
Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin. Mol Carcinog (1997) 1.09
Fluid secretion in isolated proximal straight renal tubules. Effect of human uremic serum. J Clin Invest (1973) 1.08
Polycystin-1 transforms the cAMP growth-responsive phenotype of M-1 cells. Kidney Int (2001) 1.08
Polycystic kidney disease: etiology, pathogenesis, and treatment. Dis Mon (1995) 1.08
Inhibitory effects of human sera on adenovirus-mediated gene transfer into rat liver. Anticancer Res (1998) 1.08
Necrotic inflammatory reaction induced by muramyl dipeptide in guinea pigs sensitized by tubercle bacilli. J Exp Med (1985) 1.07
Chemical structure and biological activity relationship of bacterial cell walls and muramyl peptides. Fed Proc (1986) 1.06
The role of computed tomography in the evaluation of adult polycystic kidney disease. Am J Kidney Dis (1981) 1.06
Chloride and fluid secretion by cultured human polycystic kidney cells. Kidney Int (1996) 1.06
Inhibition of macrophage DNA synthesis by immunomodulators. I. Suppression of [3H]thymidine incorporation into macrophages by MDP and LPS. Microbiol Immunol (1983) 1.06
Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats. Kidney Int (2001) 1.06
Natural history of acquired renal cystic disease in dialysis patients: a prospective longitudinal CT study. AJR Am J Roentgenol (1991) 1.05
Vanadate-stimulated natriuresis. Nature (1978) 1.05
Growth factor gene expression in kidney of murine polycystic kidney disease. J Am Soc Nephrol (1993) 1.05
Reduced sensitivity of inducible nitric oxide synthase-deficient mice to chronic colitis. Free Radic Biol Med (2001) 1.05
Increase in wild-type p53 stability and transactivational activity by the chemopreventive agent apigenin in keratinocytes. Carcinogenesis (2000) 1.05
Iron-induced oxidative brain injury after experimental intracerebral hemorrhage. Acta Neurochir Suppl (2006) 1.05
Temperature effect on ADH response of isolated perfused rabbit collecting tubules. Am J Physiol (1980) 1.03
Separation of epidermal cells by density centrifugation: a new technique for studies on normal and pathological differentiation. J Cutan Pathol (1982) 1.03
Granuloma formation by muramyl dipeptide associated with branched fatty acids, a structure probably essential for tubercle formation by Mycobacterium tuberculosis. Infect Immun (1985) 1.03
Polycystic kidney disease: a predominance of giant nephrons. Am J Physiol (1983) 1.03
Anion secretion drives fluid secretion by monolayers of cultured human polycystic cells. Am J Physiol (1995) 1.03
Involvement of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in the pathogenesis of granulomatous colitis in rats. Clin Exp Immunol (2001) 1.02
Calmodulin and calmodulin binding proteins in amphibian rod outer segments. Biochemistry (1987) 1.02
Autolytic transition of mu-calpain upon activation as resolved by antibodies distinguishing between the pre- and post-autolysis forms. J Biochem (1992) 1.02
Reversal by protein kinase C inhibitor of suppressive actions of phorbol-12-myristate-13-acetate on polyphosphoinositide metabolism and cytosolic Ca2+ mobilization in thrombin-stimulated human platelets. Biochem Biophys Res Commun (1986) 1.02
Effects of vestibulocerebellar lesions upon dynamic characteristics and adaptation of vestibulo-ocular and optokinetic responses in pigmented rabbits. Exp Brain Res (1983) 1.02
The effect of sodium hydroxide and hydrochloric acid on human epidermis. An electronmicroscopic study. Acta Derm Venereol (1972) 1.01
C-fos expression is hypersensitive to serum-stimulation in cultured cystic kidney cells from the C57BL/6J-cpk mouse. J Cell Physiol (1992) 1.01
PD-1/B7-H1 interaction contribute to the spontaneous acceptance of mouse liver allograft. Am J Transplant (2009) 1.00
Internucleotide incorporation of arabinosyladenine into herpes simplex virus and mammalian cell DNA. Virology (1981) 1.00
Increase in p53 protein half-life in mouse keratinocytes following UV-B irradiation. Carcinogenesis (1994) 1.00
Modification of disease progression in rats with inherited polycystic kidney disease. Am J Kidney Dis (1996) 0.99
Calcified renal stones and cyst calcifications in autosomal dominant polycystic kidney disease: clinical and CT study in 84 patients. AJR Am J Roentgenol (1992) 0.99
Adjuvanticity (immunity-inducing property) of cord factor in mice and rats. Infect Immun (1977) 0.98
In vitro fluid secretion by epithelium from polycystic kidneys. J Clin Invest (1995) 0.98
Isovolumetric regulation of isolated S2 proximal tubules in anisotonic media. J Clin Invest (1986) 0.98
Influence of serum proteins on net fluid reabsorption of isolated proximal tubules. Kidney Int (1972) 0.98
Effect of barium on cell volume regulation in rabbit proximal straight tubules. Am J Physiol (1985) 0.97